Dr Howard Adler, MD | |
24 Research Way, Suite 500, East Setauket, NY 11733-3453 | |
(631) 444-6270 | |
Not Available |
Full Name | Dr Howard Adler |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 34 Years |
Location | 24 Research Way, East Setauket, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306872254 | NPI | - | NPPES |
58T991 | Other | NY | EMPIRE B/C B/S |
01860728 | Medicaid | NY | |
5139677 | Other | NY | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 186526 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
John T Mather Memorial Hospital Of Port Jefferson | Port jefferson, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Stony Brook Urology University Faculty Practice Corporation | 3577454008 | 34 |
News Archive
Three years ago Mark Kay, MD, PhD, published the first results showing that a biological phenomenon called RNA interference could be an effective gene therapy technique. Since then he has used RNAi gene therapy to effectively shut down the viruses that cause hepatitis and HIV in mice.
A new study led by the Neuropharmacology Laboratory -NeuroPhar at UPF shows that increasing endocannabinoids in the brain may cause inflammation in specific brain areas such as the cerebellum, which is associated with problems of fine motor coordination.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2010 fiscal year ended June 30, 2010.
Resistance to antifungal therapy of genital-infection causing Candida species may be an increasing problem, suggests research presented at the European Academy of Dermatology and Venereology annual congress in Prague, Czech Republic.
› Verified 2 days ago
Entity Name | Stony Brook Urology University Faculty Practice Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538114707 PECOS PAC ID: 3577454008 Enrollment ID: O20040323001255 |
News Archive
Three years ago Mark Kay, MD, PhD, published the first results showing that a biological phenomenon called RNA interference could be an effective gene therapy technique. Since then he has used RNAi gene therapy to effectively shut down the viruses that cause hepatitis and HIV in mice.
A new study led by the Neuropharmacology Laboratory -NeuroPhar at UPF shows that increasing endocannabinoids in the brain may cause inflammation in specific brain areas such as the cerebellum, which is associated with problems of fine motor coordination.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2010 fiscal year ended June 30, 2010.
Resistance to antifungal therapy of genital-infection causing Candida species may be an increasing problem, suggests research presented at the European Academy of Dermatology and Venereology annual congress in Prague, Czech Republic.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Howard Adler, MD Po Box 1559, Stony Brook, NY 11790-0989 Ph: (631) 444-6270 | Dr Howard Adler, MD 24 Research Way, Suite 500, East Setauket, NY 11733-3453 Ph: (631) 444-6270 |
News Archive
Three years ago Mark Kay, MD, PhD, published the first results showing that a biological phenomenon called RNA interference could be an effective gene therapy technique. Since then he has used RNAi gene therapy to effectively shut down the viruses that cause hepatitis and HIV in mice.
A new study led by the Neuropharmacology Laboratory -NeuroPhar at UPF shows that increasing endocannabinoids in the brain may cause inflammation in specific brain areas such as the cerebellum, which is associated with problems of fine motor coordination.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2010 fiscal year ended June 30, 2010.
Resistance to antifungal therapy of genital-infection causing Candida species may be an increasing problem, suggests research presented at the European Academy of Dermatology and Venereology annual congress in Prague, Czech Republic.
› Verified 2 days ago
David L Peters, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 24 Research Way, East Setauket, NY 11733 Phone: 631-444-6270 | |
Dr. Yefim Sheynkin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24 Research Way, East Setauket, NY 11733 Phone: 631-444-6270 | |
Dr. David Schulsinger, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24 Research Way, Suite 500, East Setauket, NY 11733 Phone: 631-444-6270 | |
Dr. Wayne Waltzer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24 Research Way, Suite 500, East Setauket, NY 11733 Phone: 631-444-6270 | |
Dr. Altan Kadri Ilkay, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3400 Nesconset Hwy, Technology Dr, Suite 106, East Setauket, NY 11733 Phone: 631-751-1666 Fax: 631-751-1677 | |
Mr. Matthew Petersen, P.A. Urology Medicare: Accepting Medicare Assignments Practice Location: 24 Research Way, Suite 500, East Setauket, NY 11733 Phone: 631-444-1910 |